Indication

Haemophilus septic arthritis

Haemophilus septic arthritis is an acute, purulent joint infection caused by bacteria of the genus *Haemophilus*, most frequently *Haemophilus influenzae*. Read more about Haemophilus septic arthritis

32 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Haemophilus septic arthritis therapies.

Showing 10–18 of 32 drugs

Filter & compare in the drug finder →Opens the drug finder with Haemophilus septic arthritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Haemophilus septic arthritis.

Haemophilus septic arthritis is an acute, purulent joint infection caused by bacteria of the genus *Haemophilus*, most frequently *Haemophilus influenzae*.

Primarily affecting the synovial fluid and articular tissues of large joints—such as the knee, hip, or elbow—it historically presented most often in infants and unimmunized young children, but it also occurs in adults with underlying immunocompromising conditions, complement deficiencies, or pre-existing arthropathies.

Pathophysiologically, the bacteria seed the joint space via hematogenous dissemination from an initial respiratory tract focus or occult bacteremia, provoking intense neutrophilic inflammation that leads to joint effusion, synovial ischemia, and potential cartilage destruction.

Defining clinical manifestations include acute-onset fever, severe joint pain, swelling, erythema, and markedly restricted range of motion, typically characterized by purulent synovial fluid exhibiting pleomorphic gram-negative coccobacilli on microbiological evaluation.

Personalize your experience

Follow Haemophilus septic arthritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it